Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element.

Joseph SBaxter; NicholaJohnson; KatarzynaTomczyk; AndreaGillespie; SarahMaguire; RachelBrough; LauraFachal; KyriakiMichailidou; Manjeet KBolla; QinWang; +176 more... JoeDennis; Thomas UAhearn; Irene LAndrulis; HodaAnton-Culver; Natalia NAntonenkova; VolkerArndt; Kristan JAronson; AnnelieAugustinsson; HeikoBecher; Matthias WBeckmann; SabineBehrens; JavierBenitez; MarinaBermisheva; Natalia VBogdanova; Stig EBojesen; HermannBrenner; Sara YBrucker; QiuyinCai; DanieleCampa; FedericoCanzian; Jose ECastelao; Tsun LChan; JennyChang-Claude; Stephen JChanock; GeorgiaChenevix-Trench; Ji-YeobChoi; Christine LClarke; NBCS Collaborators; SarahColonna; Don MConroy; Fergus JCouch; AngelaCox; Simon SCross; KamilaCzene; Mary BDaly; PeterDevilee; ThiloDörk; LaureDossus; MiriamDwek; Diana MEccles; Arif BEkici; A HeatherEliassen; ChristophEngel; Peter AFasching; JonineFigueroa; HenrikFlyger; ManuelaGago-Dominguez; ChiGao; MontserratGarcía-Closas; José AGarcía-Sáenz; MayaGhoussaini; Graham GGiles; Mark SGoldberg; AnnaGonzález-Neira; PascalGuénel; MelanieGündert; LotharHaeberle; EricHahnen; Christopher AHaiman; PerHall; UteHamann; MikaelHartman; SigridHatse; JanHauke; AntoinetteHollestelle; ReinerHoppe; John LHopper; Ming-FengHou; kConFab Investigators; ABCTB Investigators; HidemiIto; MotokiIwasaki; AgnesJager; AnnaJakubowska; WolfgangJanni; Esther MJohn; VijaiJoseph; AudreyJung; RudolfKaaks; DaeheeKang; RenskeKeeman; ElzaKhusnutdinova; Sung-WonKim; Veli-MattiKosma; PeterKraft; Vessela NKristensen; KaterinaKubelka-Sabit; Allison WKurian; AvaKwong; James VLacey; DietherLambrechts; Nicole LLarson; Susanna CLarsson; LoicLe Marchand; FlavioLejbkowicz; JingmeiLi; JirongLong; ArtitayaLophatananon; JanLubiński; ArtoMannermaa; MehdiManoochehri; SiranoushManoukian; SaraMargolin; KeitaroMatsuo; DimitriosMavroudis; RebeccaMayes; UshaMenon; Roger LMilne; Nur AishahMohd Taib; KennethMuir; Taru AMuranen; Rachel AMurphy; HeliNevanlinna; Katie MO'Brien; KennethOffit; Janet EOlson; HåkanOlsson; Sue KPark; Tjoung-WonPark-Simon; Alpa VPatel; PaoloPeterlongo; Julian Peto ORCID logo; DijanaPlaseska-Karanfilska; NadegePresneau; KatriPylkäs; BrigitteRack; GadRennert; AtochaRomero; MatthiasRuebner; ThomasRüdiger; EmmanouilSaloustros; Dale PSandler; Elinor JSawyer; Marjanka KSchmidt; Rita KSchmutzler; AndreasSchneeweiss; Minouk JSchoemaker; MitulShah; Chen-YangShen; Xiao-OuShu; JacquesSimard; Melissa CSouthey; JenniferStone; HaraldSurowy; Anthony JSwerdlow; Rulla MTamimi; William JTapper; Jack ATaylor; Soo HwangTeo; Lauren RTeras; Mary BethTerry; Amanda EToland; IanTomlinson; ThérèseTruong; Chiu-ChenTseng; MichaelUntch; Celine MVachon; Ans MWvan den Ouweland; Sophia SWang; Clarice RWeinberg; CamillaWendt; Stacey JWinham; RobertWinqvist; AlicjaWolk; Anna HWu; TaikiYamaji; WeiZheng; ArgyriosZiogas; Paul DPPharoah; Alison MDunning; Douglas FEaston; Stephen JPettitt; Christopher JLord; SyedHaider; NickOrr; OliviaFletcher; (2021) Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element. AMERICAN JOURNAL OF HUMAN GENETICS, 108 (7). pp. 1190-1203. ISSN 0002-9297 DOI: 10.1016/j.ajhg.2021.05.013
Copy

A combination of genetic and functional approaches has identified three independent breast cancer risk loci at 2q35. A recent fine-scale mapping analysis to refine these associations resulted in 1 (signal 1), 5 (signal 2), and 42 (signal 3) credible causal variants at these loci. We used publicly available in silico DNase I and ChIP-seq data with in vitro reporter gene and CRISPR assays to annotate signals 2 and 3. We identified putative regulatory elements that enhanced cell-type-specific transcription from the IGFBP5 promoter at both signals (30- to 40-fold increased expression by the putative regulatory element at signal 2, 2- to 3-fold by the putative regulatory element at signal 3). We further identified one of the five credible causal variants at signal 2, a 1.4 kb deletion (esv3594306), as the likely causal variant; the deletion allele of this variant was associated with an average additional increase in IGFBP5 expression of 1.3-fold (MCF-7) and 2.2-fold (T-47D). We propose a model in which the deletion allele of esv3594306 juxtaposes two transcription factor binding regions (annotated by estrogen receptor alpha ChIP-seq peaks) to generate a single extended regulatory element. This regulatory element increases cell-type-specific expression of the tumor suppressor gene IGFBP5 and, thereby, reduces risk of estrogen receptor-positive breast cancer (odds ratio = 0.77, 95% CI 0.74-0.81, p = 3.1 × 10-31).



picture_as_pdf
Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long.pdf
subject
Published Version
Available under Creative Commons: 4.0

View Download

Explore Further

Read more research from the creator(s):

Find work associated with the faculties and division(s):

Find work from this publication: